Fulfilling our mission of translating scientific discoveries to improved standards of care...
Learn MoreLearn More
This year’s ASCO GU Cancers Symposium, held 16-18 February in San Francisco, will featur...
Learn MorePrincipal Investigators Lorelei Mucci, ScD, MPH (Harvard T.H. Chan School of Public Health...
Learn MoreNew technology provides a major step forward in diagnosing and treating prostate cancer.
Learn MoreA new manuscript published in JCO Global Oncology describes the PCCTC managed IRONMAN Regi...
Learn MoreMore than 40,000 oncology professionals from around the world will convene at the annual A...
Learn MoreNORTH BILLERICA, MA, January 27, 2022 – Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus...
Learn MoreThe Prostate Cancer Clinical Trials Consortium (PCCTC) Genetics Germline Working Group is ...
Learn MoreTowards achieving the ultimate goal of improving outcomes for patients, families, and care...
Learn MoreResearchers from Johns Hopkins University, University of Washington School of Medicine see...
Learn MoreLed by Dr. Samuel R. Denmeade and his team at Johns Hopkins School of Medicine – Sid...
Learn MorePractical considerations and challenges for germline genetic testing in patients with pros...
Learn More“Diversity of Enrollment in Prostate Cancer Clinical Trials: Current Status and Futu...
Learn MoreDr. Charles Ryan (University of Minnesota) is joined by the PCCTC’s CEO, Jake Vinson...
Learn MoreA commitment to addressing prostate cancer health disparities.
Learn MoreDr. Alicia Morgans (Northwestern University Feinberg School of Medicine) welcomes PCCTC Me...
Learn MoreAll are encouraged to participate to quickly gather details related to patients with cance...
Learn MoreNew York, NY (March 24, 2020) – In response to the ongoing COVID-19 pandemic, the PCCTC ...
Learn MoreIRONMAN – An International Registry for Men with Advanced Prostate Cancer.
Learn MoreEffort organized by BloodPAC describes minimum technical data elements for liquid biopsy d...
Learn MoreFree event featuring PCCTC advocates Jan Manarite and Joel Nowak will take place Saturday,...
Learn MoreStudy combines hormonal therapy with prostatectomy and radiation therapy of bone lesions
Learn MorePCCTC study demonstrates safety and antitumor activity of humanized immunoglobulin G1 anti...
Learn MoreAward will fund novel trial using immunotherapy combined with radiation and hormone therap...
Learn MoreStudy published in Clinical Genitourinary Cancer argues multidisciplinary efforts are key ...
Learn MoreInvestigators from the Prostate Cancer Clinical Trials Consortium (PCCTC) formed the Germl...
Learn MoreThe phase III DORA study (ClinicalTrials.gov Identifier: NCT03574571) led by PCCTC investi...
Learn MoreAR-V7 successfully predicted resistance to hormonal therapy in advanced prostate cancer
Learn MorePCCTC investigator Dr. Heather Cheng discusses future of cancer care.
Learn MoreThe PCCTC is currently seeking a Quality Manager and Clinical Data Manager to join its tea...
Learn MoreDr. Michael Morris describes the need to be stratified by risk through biomarkers.
Learn MoreThe PCCTC serves as the the program’s Global Clinical and Data Coordination Center. ...
Learn MoreManuscript published in the Journal of Clinical Oncology – Precision Oncology discus...
Learn MoreDr. Elisabeth Heath of Karmanos Cancer Institute will head up the 8th Annual Prostate Canc...
Learn MorePCCTC Scientific Oversight Committee Chair, Howard I. Scher, MD leads international study....
Learn MoreTo better meet the needs of our partners the PCCTC is expanding its infrastructure. Our ce...
Learn MorePCCTC investigator Dr. Lorelei Mucci discusses innovative new registry initiative.
Learn MoreOn February 14, 2018, the Food and Drug Administration (FDA) approved the next-generation ...
Learn MoreA pre-planned subset analysis using a polymorphism of the superoxide dismutase-2 (SOD2) ge...
Learn MoreCelebrating Veterans Week 2017, we salute Angie Avery, PCCTC Project Coordinator.
Learn MoreThe Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP)...
Learn MoreA new drug application (NDA) has been submitted to the FDA for apalutamide (ARN-509) for t...
Learn MoreThe 7th Annual Prostate Cancer Advocacy Symposium: A National Summit in Detroit brings tog...
Learn MoreTempus, a technology company focused on helping doctors personalize cancer care by collect...
Learn MoreThe PCCTC’s Scientific Oversight Committee chair speaks with UroToday at the 2017 Ad...
Learn MoreStudy represents a new standard that demonstrates the patient experience, useful for physi...
Learn MoreIRONMAN: An International Registry To Improve Outcomes in Men with Advanced Prostate Cance...
Learn MorePCCTC study serves as the foundation for a therapeutically relevant classification of pros...
Learn MoreStudy led by the University of Washington published in Clinical Cancer Research provides e...
Learn MoreThe PCCTC is currently seeking talented clinical research professionals to fill the positi...
Learn MoreThe Prostate Cancer Foundation (PCF) highlights the accomplishments of PCCTC investigator ...
Learn MoreLorelei Mucci and Phil Kantoff, MD, discuss the PCCTC-managed International Registry to Im...
Learn MoreWASHINGTON, D.C. December 20, 2016 – The Breast Cancer Research Foundation (BCRF) and th...
Learn MoreDr. Howard I. Scher, PCCTC Scientific Oversight Committee Chair, speaks on predicting sens...
Learn MoreProstate cancer is the second most common cancer in men worldwide. The PCCTC and Movember ...
Learn MorePCCTC involved with new partnership in pursuit of creating an open database for liquid ...
Learn MoreThe selective aurora A kinase inhibitor Alisertib may benefit some patients with neuroend...
Learn MoreInnovative physician-scientist exemplifies research excellence while maintaining strong co...
Learn MoreThe US Food and Drug Administration (FDA) recently granted Novartis’ CDK4/6 inhibitor LE...
Learn MoreMen with metastatic disease found more likely to harbor mutations in genes mediating DNA-r...
Learn MoreThe US Department of Defense (DoD) Prostate Cancer Research Program (PCRP), a division of...
Learn MoreATLANTA, GA and NEW YORK, June 10, 2016 – Florence Healthcare, developer of the innovati...
Learn MoreThe latest recommendations from Prostate Cancer Working Group 3 (PCWG3) have already been...
Learn MoreInnocrin’s CYP17 lyase inhibitor seviteronel (VT-464), currently in PCCTC-led early ...
Learn MoreThe Congressionally Directed Medical Research Programs (CDMRP) selects the PCCTC’s c...
Learn MoreOver 500 investigators, and research staff from PCCTC clinical research sites have come to...
Learn MoreOct. 28, 2015 — A major new trial, funded in part by the Prostate Cancer Foundation ...
Learn MorePRINCETON, N.J. and NEW YORK, Sept. 29, 2015 /PRNewswire/ — WIRB-Copernicus Group® ...
Learn MoreANN ARBOR, Mich. — An international collaboration of researchers are advancing precision...
Learn MoreSAN FRANCISCO, CA and TOKYO, JAPAN — (Marketwired) — 04/02/15 — Medivati...
Learn MoreSAN DIEGO – March 9, 2015 – Epic Sciences and The Prostate Cancer Clinical Trials Cons...
Learn MoreTo address the need for better therapies for men with high-risk localized prostate cancer,...
Learn MoreOn May15, 2013, the U. S. Food and Drug Administration (FDA) approved radium Ra 223 dichlo...
Learn MoreThe PCCTC is now accepting applications for its Affiliate Clinical Research Site program. ...
Learn MoreSurvival data from a phase II PCCTC trial of single agent tasquinimod (NCT00560482) furthe...
Learn MoreGenomic Health, Inc. announced the launch of its Oncotype DX® prostate cancer test whic...
Learn MoreOn December 10, 2012, the U. S. Food and Drug Administration (FDA) approved an expanded i...
Learn MoreJoin our team of dedicated clinical research professionals! The Prostate Cancer Clinical Trials Consortium is currently seeking a Quality Manager and Clinical Data Manager to help fulfill our…
Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.